Global pioneers in NAD+ solutions set for future clinic panel, roundtable and immersive Performance Hub activation.
NADclinic has been announced as an Innovator Partner for The Longevity Show 2026, the new two-day event landing at Tobacco Dock in London on 26–27 June.
Part conference, part public exhibition, The Longevity Show is designed to bring together the clinical, consumer and commercial sides of the longevity economy; an increasingly necessary feat, given that the sector is now less about explaining why longevity matters and more about delivering it in repeatable, measurable ways.
NADclinic’s presence leans into that shift. Where early longevity events often revolved around concepts and catalysts, the industry is now asking harder questions: how do clinics scale without diluting standards; how do experiences become protocols; how does prevention become something you can run operationally on a Tuesday afternoon, not just theorize about on a conference stage.
What NADclinic will bring to the show floor
As an Innovator Partner, NADclinic will play a central role in the Business of Longevity Conference program at The Longevity Show. Co-Founder and CEO Iain De Havilland will join a panel exploring The Longevity Clinic of 2035, sharing insights into how clinic models, technology and the patient experience are likely to evolve over the next decade.
Alongside this, NADclinic will host a roundtable session as part of the business program – a format that tends to surface the questions attendees actually care about: the operational friction points, the regulatory realities, the unglamorous but vital details of staffing, supply and standardization.
Then there is the more experiential layer. NADclinic will deliver an immersive Performance Hub activation at the heart of the event, bringing its approach to clinical longevity and optimization to life. The show itself has been positioned as a place for testing, tasting, demos and real conversation, and this kind of activation fits neatly within that promise.
Three modes of engagement – stage, table and floor. Exciting, practical and very 2026.
From NAD+ category to clinical infrastructure
NADclinic’s proposition is built around an unusually mature footprint for a specialist longevity brand. With more than a decade of NAD+ expertise and operations spanning 40+ countries, the company describes itself as a global leader in longevity and human performance, delivering NAD+ injectables, diagnostics and nutraceuticals through scalable solutions designed to integrate into premium venues.
It is, in effect, a “plug-and-play” approach to creating Longevity and Human Performance hubs – a model aimed as much at operators and venue partners as it is at end users. That’s a notable pivot point for the category; as NAD+ moves further into the mainstream longevity toolkit, clinic-grade delivery and operational scalability are becoming the differentiators – not the ingredient alone.
In parallel, NADclinic’s broader ecosystem places NAD+ alongside adjacent therapeutic interest areas such as peptides, exosomes and vitamins, reflecting the reality that today’s longevity clinic rarely sells a single modality; it builds a menu, a narrative and, ideally, a feedback loop.
None of this is accidental. Longevity is becoming infrastructural. The winners will look less like boutique concepts and more like systems.
Why NADclinic is backing The Longevity Show
For De Havilland, the partnership speaks to timing, as much as opportunity.
“Longevity is entering its execution phase,” he told us. “The Longevity Show is where operators, clinicians and innovators align to move the industry from promise to practice, and that’s exactly where we want NADclinic to be.”
From Longevity.Technology’s perspective, the partnership also aligns with the event’s intent to connect innovation with delivery rather than leaving them as parallel conversations.
“We’re thrilled to welcome NADclinic to The Longevity Show 2026,” said Phil Newman, cofounder of the Longevity Show and Longevity.Technology CEO. “As they scale their specialist NAD brand internationally, their presence reflects the innovation shaping the wellness and longevity space. With a rapidly expanding international footprint, NADclinic continues to raise the bar for excellence in performance and health optimization. NAD+ supplementation is such a cornerstone to people’s healthspan, and we’re excited for their team to share their knowledge with both business and consumer attendees at this year’s event.”
Signals worth watching
Expect NADclinic’s presence to spark discussion around standardization, outcomes tracking and how premium wellness spaces evolve into medically supported longevity hubs. The clinic of the future is not just a prettier waiting room; it is data architecture, supply chain discipline and a patient journey designed for adherence rather than aspiration.
It is also, albeit quietly, a test of the longevity sector’s maturity. The science is advancing at speed; now the ecosystem has to keep pace. While not glamorous, this is essential.
To learn more about partnership and exhibitor opportunities at The Longevity Show 2026, contact the Sponsor & Exhibitor team.
The Longevity Show opens its doors on 26–27 June 2026 at Tobacco Dock, London. Early bird tickets for all tiers are now available at www.longevityshow.com until 28 February 2026.
